Article Versions Notes

Thümmler L, Beckmann N, Sehl C, Soddemann M, Braß P, Bormann M, Brochhagen L, Elsner C, Hoertel N, Cougoule C, et al. Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants. Viruses. 2024; 16(4):545. https://doi.org/10.3390/v16040545

Thümmler, Laura, Nadine Beckmann, Carolin Sehl, Matthias Soddemann, Peer Braß, Maren Bormann, Leonie Brochhagen, Carina Elsner, Nicolas Hoertel, Céline Cougoule, and et al. 2024. "Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants" Viruses 16, no. 4: 545. https://doi.org/10.3390/v16040545

Thümmler, L., Beckmann, N., Sehl, C., Soddemann, M., Braß, P., Bormann, M., Brochhagen, L., Elsner, C., Hoertel, N., Cougoule, C., Ciesek, S., Widera, M., Dittmer, U., Lindemann, M., Horn, P. A., Witzke, O., Kadow, S., Kamler, M., Gulbins, E., ... Krawczyk, A. (2024). Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants. Viruses, 16(4), 545. https://doi.org/10.3390/v16040545